nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP11A1—uterine cancer	0.391	1	CbGaD
Omeprazole—CYP1B1—Progesterone—uterine cancer	0.0662	0.159	CbGbCtD
Omeprazole—ABCC3—Etoposide—uterine cancer	0.0343	0.0825	CbGbCtD
Omeprazole—CYP1A1—Progesterone—uterine cancer	0.029	0.07	CbGbCtD
Omeprazole—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0253	0.0609	CbGbCtD
Omeprazole—ABCG2—Dactinomycin—uterine cancer	0.025	0.0601	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—uterine cancer	0.0234	0.0563	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—uterine cancer	0.0202	0.0487	CbGbCtD
Omeprazole—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0176	0.0425	CbGbCtD
Omeprazole—ABCG2—Carboplatin—uterine cancer	0.0168	0.0404	CbGbCtD
Omeprazole—CYP2C8—Progesterone—uterine cancer	0.0168	0.0404	CbGbCtD
Omeprazole—ABCG2—Etoposide—uterine cancer	0.0141	0.0339	CbGbCtD
Omeprazole—CYP2C19—Progesterone—uterine cancer	0.0141	0.0339	CbGbCtD
Omeprazole—CYP1A2—Progesterone—uterine cancer	0.013	0.0313	CbGbCtD
Omeprazole—CYP2C9—Progesterone—uterine cancer	0.0117	0.0282	CbGbCtD
Omeprazole—ABCB1—Progesterone—uterine cancer	0.0113	0.0273	CbGbCtD
Omeprazole—CYP2D6—Progesterone—uterine cancer	0.0107	0.0257	CbGbCtD
Omeprazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0103	0.0247	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—uterine cancer	0.0096	0.0231	CbGbCtD
Omeprazole—CYP11A1—corpus luteum—uterine cancer	0.00956	0.286	CbGeAlD
Omeprazole—ABCB1—Dactinomycin—uterine cancer	0.009	0.0217	CbGbCtD
Omeprazole—CYP2C8—Etoposide—uterine cancer	0.0075	0.0181	CbGbCtD
Omeprazole—CYP3A4—Progesterone—uterine cancer	0.0068	0.0164	CbGbCtD
Omeprazole—CYP1A2—Etoposide—uterine cancer	0.00581	0.014	CbGbCtD
Omeprazole—ABCB1—Etoposide—uterine cancer	0.00508	0.0122	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—uterine cancer	0.00346	0.00834	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—uterine cancer	0.00326	0.00786	CbGbCtD
Omeprazole—CYP3A4—Etoposide—uterine cancer	0.00304	0.00733	CbGbCtD
Omeprazole—CYP3A4—Doxorubicin—uterine cancer	0.00207	0.005	CbGbCtD
Omeprazole—ATP4A—epithelium—uterine cancer	0.00126	0.0377	CbGeAlD
Omeprazole—ATP4A—renal system—uterine cancer	0.00117	0.035	CbGeAlD
Omeprazole—CYP2C18—uterine cervix—uterine cancer	0.00103	0.0307	CbGeAlD
Omeprazole—ATP4A—female reproductive system—uterine cancer	0.000935	0.028	CbGeAlD
Omeprazole—CYP2C18—mammalian vulva—uterine cancer	0.000897	0.0269	CbGeAlD
Omeprazole—CYP11A1—decidua—uterine cancer	0.000779	0.0233	CbGeAlD
Omeprazole—CYP2C18—vagina—uterine cancer	0.000695	0.0208	CbGeAlD
Omeprazole—CYP11A1—female reproductive system—uterine cancer	0.000613	0.0183	CbGeAlD
Omeprazole—ABCC3—decidua—uterine cancer	0.000605	0.0181	CbGeAlD
Omeprazole—ABCC3—renal system—uterine cancer	0.000594	0.0178	CbGeAlD
Omeprazole—CYP11A1—female gonad—uterine cancer	0.000558	0.0167	CbGeAlD
Omeprazole—CYP1B1—smooth muscle tissue—uterine cancer	0.000483	0.0145	CbGeAlD
Omeprazole—ABCC3—female reproductive system—uterine cancer	0.000476	0.0142	CbGeAlD
Omeprazole—ABCG2—myometrium—uterine cancer	0.000475	0.0142	CbGeAlD
Omeprazole—CYP1B1—decidua—uterine cancer	0.000473	0.0142	CbGeAlD
Omeprazole—CYP1B1—renal system—uterine cancer	0.000465	0.0139	CbGeAlD
Omeprazole—ABCC3—female gonad—uterine cancer	0.000433	0.013	CbGeAlD
Omeprazole—CYP1B1—uterus—uterine cancer	0.000414	0.0124	CbGeAlD
Omeprazole—CYP1B1—female reproductive system—uterine cancer	0.000372	0.0111	CbGeAlD
Omeprazole—ABCG2—uterine cervix—uterine cancer	0.00037	0.0111	CbGeAlD
Omeprazole—CYP11A1—lymph node—uterine cancer	0.000359	0.0107	CbGeAlD
Omeprazole—CYP2C8—renal system—uterine cancer	0.000356	0.0107	CbGeAlD
Omeprazole—CYP1A1—epithelium—uterine cancer	0.000354	0.0106	CbGeAlD
Omeprazole—ABCG2—decidua—uterine cancer	0.000352	0.0106	CbGeAlD
Omeprazole—CYP1A1—uterine cervix—uterine cancer	0.000351	0.0105	CbGeAlD
Omeprazole—CYP2C8—endometrium—uterine cancer	0.000344	0.0103	CbGeAlD
Omeprazole—CYP1B1—female gonad—uterine cancer	0.000339	0.0101	CbGeAlD
Omeprazole—ABCG2—endometrium—uterine cancer	0.000335	0.01	CbGeAlD
Omeprazole—CYP1A2—renal system—uterine cancer	0.000333	0.00997	CbGeAlD
Omeprazole—CYP1A1—renal system—uterine cancer	0.000329	0.00984	CbGeAlD
Omeprazole—ABCG2—mammalian vulva—uterine cancer	0.000324	0.00969	CbGeAlD
Omeprazole—ABCG2—uterus—uterine cancer	0.000308	0.00923	CbGeAlD
Omeprazole—CYP1A1—mammalian vulva—uterine cancer	0.000307	0.0092	CbGeAlD
Omeprazole—CYP2C19—vagina—uterine cancer	0.000295	0.00884	CbGeAlD
Omeprazole—CYP1A1—uterus—uterine cancer	0.000293	0.00876	CbGeAlD
Omeprazole—CYP2C8—female reproductive system—uterine cancer	0.000285	0.00854	CbGeAlD
Omeprazole—ABCC3—lymph node—uterine cancer	0.000278	0.00833	CbGeAlD
Omeprazole—CYP1A1—female reproductive system—uterine cancer	0.000263	0.00788	CbGeAlD
Omeprazole—CYP2C8—vagina—uterine cancer	0.000258	0.00772	CbGeAlD
Omeprazole—CYP2C9—female reproductive system—uterine cancer	0.000253	0.00758	CbGeAlD
Omeprazole—ABCG2—female gonad—uterine cancer	0.000252	0.00755	CbGeAlD
Omeprazole—ABCG2—vagina—uterine cancer	0.000251	0.00751	CbGeAlD
Omeprazole—CYP3A4—renal system—uterine cancer	0.000241	0.00722	CbGeAlD
Omeprazole—CYP1A1—female gonad—uterine cancer	0.000239	0.00717	CbGeAlD
Omeprazole—CYP1A1—vagina—uterine cancer	0.000238	0.00713	CbGeAlD
Omeprazole—CYP2D6—renal system—uterine cancer	0.000237	0.0071	CbGeAlD
Omeprazole—ABCB1—myometrium—uterine cancer	0.000234	0.00702	CbGeAlD
Omeprazole—CYP1B1—lymph node—uterine cancer	0.000218	0.00652	CbGeAlD
Omeprazole—CYP3A4—female reproductive system—uterine cancer	0.000193	0.00578	CbGeAlD
Omeprazole—CYP2D6—female reproductive system—uterine cancer	0.00019	0.00569	CbGeAlD
Omeprazole—ABCB1—epithelium—uterine cancer	0.000184	0.00551	CbGeAlD
Omeprazole—ABCB1—uterine cervix—uterine cancer	0.000182	0.00546	CbGeAlD
Omeprazole—ABCB1—decidua—uterine cancer	0.000174	0.0052	CbGeAlD
Omeprazole—CYP2D6—female gonad—uterine cancer	0.000173	0.00518	CbGeAlD
Omeprazole—ABCB1—renal system—uterine cancer	0.000171	0.00511	CbGeAlD
Omeprazole—ABCB1—endometrium—uterine cancer	0.000165	0.00494	CbGeAlD
Omeprazole—ABCG2—lymph node—uterine cancer	0.000162	0.00485	CbGeAlD
Omeprazole—ABCB1—mammalian vulva—uterine cancer	0.00016	0.00478	CbGeAlD
Omeprazole—CYP1A1—lymph node—uterine cancer	0.000154	0.00461	CbGeAlD
Omeprazole—ABCB1—uterus—uterine cancer	0.000152	0.00455	CbGeAlD
Omeprazole—ABCB1—female reproductive system—uterine cancer	0.000137	0.00409	CbGeAlD
Omeprazole—ABCB1—female gonad—uterine cancer	0.000124	0.00372	CbGeAlD
Omeprazole—ABCB1—vagina—uterine cancer	0.000124	0.0037	CbGeAlD
Omeprazole—ABCB1—lymph node—uterine cancer	8e-05	0.00239	CbGeAlD
Omeprazole—Dysphagia—Epirubicin—uterine cancer	7.11e-05	0.000592	CcSEcCtD
Omeprazole—Thrombocytopenia—Etoposide—uterine cancer	7.06e-05	0.000588	CcSEcCtD
Omeprazole—Tachycardia—Etoposide—uterine cancer	7.04e-05	0.000587	CcSEcCtD
Omeprazole—Skin disorder—Etoposide—uterine cancer	7e-05	0.000584	CcSEcCtD
Omeprazole—Dry skin—Doxorubicin—uterine cancer	6.97e-05	0.000581	CcSEcCtD
Omeprazole—Hyperhidrosis—Etoposide—uterine cancer	6.97e-05	0.000581	CcSEcCtD
Omeprazole—Pancreatitis—Epirubicin—uterine cancer	6.97e-05	0.000581	CcSEcCtD
Omeprazole—Abdominal pain upper—Doxorubicin—uterine cancer	6.95e-05	0.000579	CcSEcCtD
Omeprazole—Hypokalaemia—Doxorubicin—uterine cancer	6.93e-05	0.000577	CcSEcCtD
Omeprazole—Angina pectoris—Epirubicin—uterine cancer	6.92e-05	0.000577	CcSEcCtD
Omeprazole—Breast disorder—Doxorubicin—uterine cancer	6.88e-05	0.000573	CcSEcCtD
Omeprazole—Anorexia—Etoposide—uterine cancer	6.87e-05	0.000573	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	6.85e-05	0.000571	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	6.85e-05	0.000571	CcSEcCtD
Omeprazole—Diarrhoea—Dactinomycin—uterine cancer	6.82e-05	0.000568	CcSEcCtD
Omeprazole—Pancytopenia—Epirubicin—uterine cancer	6.75e-05	0.000563	CcSEcCtD
Omeprazole—Gastritis—Doxorubicin—uterine cancer	6.73e-05	0.000561	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Doxorubicin—uterine cancer	6.71e-05	0.000559	CcSEcCtD
Omeprazole—Muscular weakness—Doxorubicin—uterine cancer	6.71e-05	0.000559	CcSEcCtD
Omeprazole—Neutropenia—Epirubicin—uterine cancer	6.65e-05	0.000554	CcSEcCtD
Omeprazole—Dysuria—Epirubicin—uterine cancer	6.65e-05	0.000554	CcSEcCtD
Omeprazole—Abdominal distension—Doxorubicin—uterine cancer	6.62e-05	0.000552	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Epirubicin—uterine cancer	6.61e-05	0.000551	CcSEcCtD
Omeprazole—Asthma—Doxorubicin—uterine cancer	6.58e-05	0.000548	CcSEcCtD
Omeprazole—Influenza—Doxorubicin—uterine cancer	6.58e-05	0.000548	CcSEcCtD
Omeprazole—Dysphagia—Doxorubicin—uterine cancer	6.58e-05	0.000548	CcSEcCtD
Omeprazole—Pollakiuria—Epirubicin—uterine cancer	6.57e-05	0.000547	CcSEcCtD
Omeprazole—Photosensitivity reaction—Epirubicin—uterine cancer	6.49e-05	0.000541	CcSEcCtD
Omeprazole—Paraesthesia—Etoposide—uterine cancer	6.48e-05	0.00054	CcSEcCtD
Omeprazole—Weight increased—Epirubicin—uterine cancer	6.47e-05	0.000539	CcSEcCtD
Omeprazole—Pancreatitis—Doxorubicin—uterine cancer	6.45e-05	0.000537	CcSEcCtD
Omeprazole—Weight decreased—Epirubicin—uterine cancer	6.43e-05	0.000536	CcSEcCtD
Omeprazole—Dyspnoea—Etoposide—uterine cancer	6.43e-05	0.000536	CcSEcCtD
Omeprazole—Somnolence—Etoposide—uterine cancer	6.41e-05	0.000534	CcSEcCtD
Omeprazole—Angina pectoris—Doxorubicin—uterine cancer	6.41e-05	0.000534	CcSEcCtD
Omeprazole—Infestation NOS—Epirubicin—uterine cancer	6.34e-05	0.000528	CcSEcCtD
Omeprazole—Infestation—Epirubicin—uterine cancer	6.34e-05	0.000528	CcSEcCtD
Omeprazole—Vomiting—Dactinomycin—uterine cancer	6.33e-05	0.000528	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Epirubicin—uterine cancer	6.28e-05	0.000524	CcSEcCtD
Omeprazole—Rash—Dactinomycin—uterine cancer	6.28e-05	0.000524	CcSEcCtD
Omeprazole—Decreased appetite—Etoposide—uterine cancer	6.27e-05	0.000522	CcSEcCtD
Omeprazole—Pancytopenia—Doxorubicin—uterine cancer	6.25e-05	0.000521	CcSEcCtD
Omeprazole—Renal failure—Epirubicin—uterine cancer	6.23e-05	0.000519	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Etoposide—uterine cancer	6.23e-05	0.000519	CcSEcCtD
Omeprazole—Fatigue—Etoposide—uterine cancer	6.22e-05	0.000518	CcSEcCtD
Omeprazole—Jaundice—Epirubicin—uterine cancer	6.18e-05	0.000515	CcSEcCtD
Omeprazole—Stomatitis—Epirubicin—uterine cancer	6.18e-05	0.000515	CcSEcCtD
Omeprazole—Pain—Etoposide—uterine cancer	6.17e-05	0.000514	CcSEcCtD
Omeprazole—Constipation—Etoposide—uterine cancer	6.17e-05	0.000514	CcSEcCtD
Omeprazole—Urinary tract infection—Epirubicin—uterine cancer	6.16e-05	0.000513	CcSEcCtD
Omeprazole—Conjunctivitis—Epirubicin—uterine cancer	6.16e-05	0.000513	CcSEcCtD
Omeprazole—Dysuria—Doxorubicin—uterine cancer	6.15e-05	0.000513	CcSEcCtD
Omeprazole—Neutropenia—Doxorubicin—uterine cancer	6.15e-05	0.000513	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Doxorubicin—uterine cancer	6.11e-05	0.000509	CcSEcCtD
Omeprazole—Pollakiuria—Doxorubicin—uterine cancer	6.08e-05	0.000506	CcSEcCtD
Omeprazole—Haematuria—Epirubicin—uterine cancer	6.04e-05	0.000504	CcSEcCtD
Omeprazole—Photosensitivity reaction—Doxorubicin—uterine cancer	6e-05	0.0005	CcSEcCtD
Omeprazole—Hepatobiliary disease—Epirubicin—uterine cancer	5.99e-05	0.0005	CcSEcCtD
Omeprazole—Weight increased—Doxorubicin—uterine cancer	5.99e-05	0.000499	CcSEcCtD
Omeprazole—Epistaxis—Epirubicin—uterine cancer	5.98e-05	0.000498	CcSEcCtD
Omeprazole—Weight decreased—Doxorubicin—uterine cancer	5.95e-05	0.000496	CcSEcCtD
Omeprazole—Sinusitis—Epirubicin—uterine cancer	5.95e-05	0.000496	CcSEcCtD
Omeprazole—Feeling abnormal—Etoposide—uterine cancer	5.94e-05	0.000495	CcSEcCtD
Omeprazole—Nausea—Dactinomycin—uterine cancer	5.92e-05	0.000493	CcSEcCtD
Omeprazole—Agranulocytosis—Epirubicin—uterine cancer	5.91e-05	0.000493	CcSEcCtD
Omeprazole—Gastrointestinal pain—Etoposide—uterine cancer	5.9e-05	0.000491	CcSEcCtD
Omeprazole—Infestation NOS—Doxorubicin—uterine cancer	5.86e-05	0.000489	CcSEcCtD
Omeprazole—Infestation—Doxorubicin—uterine cancer	5.86e-05	0.000489	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	5.81e-05	0.000485	CcSEcCtD
Omeprazole—Bradycardia—Epirubicin—uterine cancer	5.79e-05	0.000483	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—uterine cancer	5.76e-05	0.00048	CcSEcCtD
Omeprazole—Urticaria—Etoposide—uterine cancer	5.73e-05	0.000477	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—uterine cancer	5.72e-05	0.000476	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—uterine cancer	5.72e-05	0.000476	CcSEcCtD
Omeprazole—Rhinitis—Epirubicin—uterine cancer	5.7e-05	0.000475	CcSEcCtD
Omeprazole—Body temperature increased—Etoposide—uterine cancer	5.7e-05	0.000475	CcSEcCtD
Omeprazole—Abdominal pain—Etoposide—uterine cancer	5.7e-05	0.000475	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—uterine cancer	5.7e-05	0.000475	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—uterine cancer	5.7e-05	0.000475	CcSEcCtD
Omeprazole—Hepatitis—Epirubicin—uterine cancer	5.69e-05	0.000474	CcSEcCtD
Omeprazole—Hypoaesthesia—Epirubicin—uterine cancer	5.66e-05	0.000472	CcSEcCtD
Omeprazole—Pharyngitis—Epirubicin—uterine cancer	5.65e-05	0.000471	CcSEcCtD
Omeprazole—Urinary tract disorder—Epirubicin—uterine cancer	5.62e-05	0.000468	CcSEcCtD
Omeprazole—Oedema peripheral—Epirubicin—uterine cancer	5.6e-05	0.000467	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—uterine cancer	5.59e-05	0.000466	CcSEcCtD
Omeprazole—Connective tissue disorder—Epirubicin—uterine cancer	5.59e-05	0.000466	CcSEcCtD
Omeprazole—Urethral disorder—Epirubicin—uterine cancer	5.58e-05	0.000465	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—uterine cancer	5.55e-05	0.000462	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—uterine cancer	5.53e-05	0.000461	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—uterine cancer	5.5e-05	0.000459	CcSEcCtD
Omeprazole—Visual impairment—Epirubicin—uterine cancer	5.48e-05	0.000457	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—uterine cancer	5.47e-05	0.000456	CcSEcCtD
Omeprazole—Erythema multiforme—Epirubicin—uterine cancer	5.38e-05	0.000448	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—uterine cancer	5.36e-05	0.000447	CcSEcCtD
Omeprazole—Eye disorder—Epirubicin—uterine cancer	5.32e-05	0.000443	CcSEcCtD
Omeprazole—Hypersensitivity—Etoposide—uterine cancer	5.31e-05	0.000443	CcSEcCtD
Omeprazole—Tinnitus—Epirubicin—uterine cancer	5.3e-05	0.000442	CcSEcCtD
Omeprazole—Flushing—Epirubicin—uterine cancer	5.28e-05	0.00044	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—uterine cancer	5.28e-05	0.00044	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—uterine cancer	5.26e-05	0.000439	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—uterine cancer	5.24e-05	0.000437	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—uterine cancer	5.22e-05	0.000435	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—uterine cancer	5.2e-05	0.000433	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—uterine cancer	5.19e-05	0.000432	CcSEcCtD
Omeprazole—Asthenia—Etoposide—uterine cancer	5.17e-05	0.000431	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—uterine cancer	5.17e-05	0.000431	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—uterine cancer	5.16e-05	0.00043	CcSEcCtD
Omeprazole—Immune system disorder—Epirubicin—uterine cancer	5.14e-05	0.000428	CcSEcCtD
Omeprazole—Mediastinal disorder—Epirubicin—uterine cancer	5.13e-05	0.000427	CcSEcCtD
Omeprazole—Chills—Epirubicin—uterine cancer	5.1e-05	0.000425	CcSEcCtD
Omeprazole—Pruritus—Etoposide—uterine cancer	5.1e-05	0.000425	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—uterine cancer	5.07e-05	0.000423	CcSEcCtD
Omeprazole—Alopecia—Epirubicin—uterine cancer	5.03e-05	0.000419	CcSEcCtD
Omeprazole—Mental disorder—Epirubicin—uterine cancer	4.98e-05	0.000415	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—uterine cancer	4.98e-05	0.000415	CcSEcCtD
Omeprazole—Malnutrition—Epirubicin—uterine cancer	4.95e-05	0.000413	CcSEcCtD
Omeprazole—Diarrhoea—Etoposide—uterine cancer	4.93e-05	0.000411	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—uterine cancer	4.92e-05	0.00041	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—uterine cancer	4.91e-05	0.000409	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—uterine cancer	4.89e-05	0.000407	CcSEcCtD
Omeprazole—Flatulence—Epirubicin—uterine cancer	4.88e-05	0.000407	CcSEcCtD
Omeprazole—Tension—Epirubicin—uterine cancer	4.86e-05	0.000405	CcSEcCtD
Omeprazole—Dysgeusia—Epirubicin—uterine cancer	4.85e-05	0.000404	CcSEcCtD
Omeprazole—Nervousness—Epirubicin—uterine cancer	4.81e-05	0.000401	CcSEcCtD
Omeprazole—Back pain—Epirubicin—uterine cancer	4.79e-05	0.000399	CcSEcCtD
Omeprazole—Dizziness—Etoposide—uterine cancer	4.77e-05	0.000397	CcSEcCtD
Omeprazole—Muscle spasms—Epirubicin—uterine cancer	4.76e-05	0.000397	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—uterine cancer	4.75e-05	0.000396	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—uterine cancer	4.74e-05	0.000395	CcSEcCtD
Omeprazole—Chills—Doxorubicin—uterine cancer	4.72e-05	0.000394	CcSEcCtD
Omeprazole—Vision blurred—Epirubicin—uterine cancer	4.67e-05	0.000389	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—uterine cancer	4.65e-05	0.000388	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—uterine cancer	4.61e-05	0.000384	CcSEcCtD
Omeprazole—Ill-defined disorder—Epirubicin—uterine cancer	4.6e-05	0.000383	CcSEcCtD
Omeprazole—Vomiting—Etoposide—uterine cancer	4.58e-05	0.000382	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—uterine cancer	4.58e-05	0.000382	CcSEcCtD
Omeprazole—Anaemia—Epirubicin—uterine cancer	4.58e-05	0.000382	CcSEcCtD
Omeprazole—Agitation—Epirubicin—uterine cancer	4.55e-05	0.000379	CcSEcCtD
Omeprazole—Rash—Etoposide—uterine cancer	4.55e-05	0.000379	CcSEcCtD
Omeprazole—Dermatitis—Etoposide—uterine cancer	4.54e-05	0.000379	CcSEcCtD
Omeprazole—Headache—Etoposide—uterine cancer	4.52e-05	0.000377	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—uterine cancer	4.52e-05	0.000376	CcSEcCtD
Omeprazole—Tension—Doxorubicin—uterine cancer	4.5e-05	0.000375	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—uterine cancer	4.49e-05	0.000374	CcSEcCtD
Omeprazole—Malaise—Epirubicin—uterine cancer	4.47e-05	0.000372	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—uterine cancer	4.45e-05	0.000371	CcSEcCtD
Omeprazole—Vertigo—Epirubicin—uterine cancer	4.45e-05	0.000371	CcSEcCtD
Omeprazole—Leukopenia—Epirubicin—uterine cancer	4.43e-05	0.00037	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—uterine cancer	4.43e-05	0.000369	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—uterine cancer	4.41e-05	0.000367	CcSEcCtD
Omeprazole—Palpitations—Epirubicin—uterine cancer	4.38e-05	0.000365	CcSEcCtD
Omeprazole—Cough—Epirubicin—uterine cancer	4.32e-05	0.00036	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—uterine cancer	4.32e-05	0.00036	CcSEcCtD
Omeprazole—Nausea—Etoposide—uterine cancer	4.28e-05	0.000357	CcSEcCtD
Omeprazole—Hypertension—Epirubicin—uterine cancer	4.28e-05	0.000356	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—uterine cancer	4.25e-05	0.000354	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—uterine cancer	4.24e-05	0.000353	CcSEcCtD
Omeprazole—Chest pain—Epirubicin—uterine cancer	4.22e-05	0.000351	CcSEcCtD
Omeprazole—Arthralgia—Epirubicin—uterine cancer	4.22e-05	0.000351	CcSEcCtD
Omeprazole—Myalgia—Epirubicin—uterine cancer	4.22e-05	0.000351	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—uterine cancer	4.21e-05	0.000351	CcSEcCtD
Omeprazole—Anxiety—Epirubicin—uterine cancer	4.2e-05	0.00035	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	4.19e-05	0.000349	CcSEcCtD
Omeprazole—Discomfort—Epirubicin—uterine cancer	4.17e-05	0.000347	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—uterine cancer	4.13e-05	0.000344	CcSEcCtD
Omeprazole—Dry mouth—Epirubicin—uterine cancer	4.12e-05	0.000344	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—uterine cancer	4.12e-05	0.000343	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—uterine cancer	4.1e-05	0.000342	CcSEcCtD
Omeprazole—Confusional state—Epirubicin—uterine cancer	4.08e-05	0.00034	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—uterine cancer	4.05e-05	0.000338	CcSEcCtD
Omeprazole—Anaphylactic shock—Epirubicin—uterine cancer	4.04e-05	0.000337	CcSEcCtD
Omeprazole—Infection—Epirubicin—uterine cancer	4.02e-05	0.000335	CcSEcCtD
Omeprazole—Cough—Doxorubicin—uterine cancer	4e-05	0.000333	CcSEcCtD
Omeprazole—Shock—Epirubicin—uterine cancer	3.98e-05	0.000331	CcSEcCtD
Omeprazole—Nervous system disorder—Epirubicin—uterine cancer	3.96e-05	0.00033	CcSEcCtD
Omeprazole—Thrombocytopenia—Epirubicin—uterine cancer	3.96e-05	0.00033	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—uterine cancer	3.96e-05	0.00033	CcSEcCtD
Omeprazole—Tachycardia—Epirubicin—uterine cancer	3.94e-05	0.000329	CcSEcCtD
Omeprazole—Skin disorder—Epirubicin—uterine cancer	3.93e-05	0.000327	CcSEcCtD
Omeprazole—Hyperhidrosis—Epirubicin—uterine cancer	3.91e-05	0.000326	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—uterine cancer	3.9e-05	0.000325	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—uterine cancer	3.9e-05	0.000325	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—uterine cancer	3.9e-05	0.000325	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—uterine cancer	3.89e-05	0.000324	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	3.87e-05	0.000323	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—uterine cancer	3.85e-05	0.000321	CcSEcCtD
Omeprazole—Anorexia—Epirubicin—uterine cancer	3.85e-05	0.000321	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—uterine cancer	3.82e-05	0.000318	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—uterine cancer	3.77e-05	0.000314	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—uterine cancer	3.74e-05	0.000312	CcSEcCtD
Omeprazole—Infection—Doxorubicin—uterine cancer	3.72e-05	0.00031	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	3.68e-05	0.000307	CcSEcCtD
Omeprazole—Shock—Doxorubicin—uterine cancer	3.68e-05	0.000307	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—uterine cancer	3.67e-05	0.000306	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—uterine cancer	3.66e-05	0.000305	CcSEcCtD
Omeprazole—Insomnia—Epirubicin—uterine cancer	3.66e-05	0.000305	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—uterine cancer	3.65e-05	0.000304	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—uterine cancer	3.63e-05	0.000303	CcSEcCtD
Omeprazole—Paraesthesia—Epirubicin—uterine cancer	3.63e-05	0.000303	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—uterine cancer	3.62e-05	0.000301	CcSEcCtD
Omeprazole—Dyspnoea—Epirubicin—uterine cancer	3.6e-05	0.0003	CcSEcCtD
Omeprazole—Somnolence—Epirubicin—uterine cancer	3.59e-05	0.0003	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—uterine cancer	3.57e-05	0.000297	CcSEcCtD
Omeprazole—Dyspepsia—Epirubicin—uterine cancer	3.56e-05	0.000297	CcSEcCtD
Omeprazole—Decreased appetite—Epirubicin—uterine cancer	3.51e-05	0.000293	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Epirubicin—uterine cancer	3.49e-05	0.000291	CcSEcCtD
Omeprazole—Fatigue—Epirubicin—uterine cancer	3.48e-05	0.00029	CcSEcCtD
Omeprazole—Pain—Epirubicin—uterine cancer	3.46e-05	0.000288	CcSEcCtD
Omeprazole—Constipation—Epirubicin—uterine cancer	3.46e-05	0.000288	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	3.41e-05	0.000284	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—uterine cancer	3.38e-05	0.000282	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—uterine cancer	3.36e-05	0.00028	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—uterine cancer	3.33e-05	0.000278	CcSEcCtD
Omeprazole—Feeling abnormal—Epirubicin—uterine cancer	3.33e-05	0.000278	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—uterine cancer	3.32e-05	0.000277	CcSEcCtD
Omeprazole—Gastrointestinal pain—Epirubicin—uterine cancer	3.31e-05	0.000275	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—uterine cancer	3.29e-05	0.000274	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—uterine cancer	3.25e-05	0.000271	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—uterine cancer	3.23e-05	0.000269	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—uterine cancer	3.22e-05	0.000269	CcSEcCtD
Omeprazole—Urticaria—Epirubicin—uterine cancer	3.21e-05	0.000268	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—uterine cancer	3.2e-05	0.000267	CcSEcCtD
Omeprazole—Pain—Doxorubicin—uterine cancer	3.2e-05	0.000267	CcSEcCtD
Omeprazole—Abdominal pain—Epirubicin—uterine cancer	3.2e-05	0.000266	CcSEcCtD
Omeprazole—Body temperature increased—Epirubicin—uterine cancer	3.2e-05	0.000266	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—uterine cancer	3.08e-05	0.000257	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—uterine cancer	3.06e-05	0.000255	CcSEcCtD
Omeprazole—Hypersensitivity—Epirubicin—uterine cancer	2.98e-05	0.000248	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—uterine cancer	2.97e-05	0.000248	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—uterine cancer	2.96e-05	0.000246	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—uterine cancer	2.96e-05	0.000246	CcSEcCtD
Omeprazole—Asthenia—Epirubicin—uterine cancer	2.9e-05	0.000242	CcSEcCtD
Omeprazole—Pruritus—Epirubicin—uterine cancer	2.86e-05	0.000238	CcSEcCtD
Omeprazole—Diarrhoea—Epirubicin—uterine cancer	2.77e-05	0.000231	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—uterine cancer	2.76e-05	0.00023	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—uterine cancer	2.68e-05	0.000224	CcSEcCtD
Omeprazole—Dizziness—Epirubicin—uterine cancer	2.67e-05	0.000223	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—uterine cancer	2.65e-05	0.000221	CcSEcCtD
Omeprazole—Vomiting—Epirubicin—uterine cancer	2.57e-05	0.000214	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—uterine cancer	2.56e-05	0.000213	CcSEcCtD
Omeprazole—Rash—Epirubicin—uterine cancer	2.55e-05	0.000212	CcSEcCtD
Omeprazole—Dermatitis—Epirubicin—uterine cancer	2.55e-05	0.000212	CcSEcCtD
Omeprazole—Headache—Epirubicin—uterine cancer	2.53e-05	0.000211	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—uterine cancer	2.47e-05	0.000206	CcSEcCtD
Omeprazole—Nausea—Epirubicin—uterine cancer	2.4e-05	0.0002	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—uterine cancer	2.38e-05	0.000198	CcSEcCtD
Omeprazole—Rash—Doxorubicin—uterine cancer	2.36e-05	0.000197	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—uterine cancer	2.36e-05	0.000196	CcSEcCtD
Omeprazole—Headache—Doxorubicin—uterine cancer	2.34e-05	0.000195	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—uterine cancer	2.22e-05	0.000185	CcSEcCtD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.14e-05	0.000529	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.14e-05	0.000529	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—RRM2—uterine cancer	2.1e-05	0.000518	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—DCN—uterine cancer	2.09e-05	0.000517	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NDUFB11—uterine cancer	2.07e-05	0.000511	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SRD5A2—uterine cancer	2.07e-05	0.000511	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—DCN—uterine cancer	2.03e-05	0.000503	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.02e-05	0.000498	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.01e-05	0.000496	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CYP11A1—uterine cancer	1.97e-05	0.000487	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.92e-05	0.000475	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CYP11A1—uterine cancer	1.92e-05	0.000474	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—POLD1—uterine cancer	1.9e-05	0.000471	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.9e-05	0.000469	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SRD5A2—uterine cancer	1.9e-05	0.000469	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NDUFB11—uterine cancer	1.9e-05	0.000469	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.89e-05	0.000468	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.89e-05	0.000467	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.87e-05	0.000462	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKR1C3—uterine cancer	1.86e-05	0.00046	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.84e-05	0.000455	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.84e-05	0.000454	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKR1C3—uterine cancer	1.81e-05	0.000447	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKR1C1—uterine cancer	1.78e-05	0.00044	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.74e-05	0.00043	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—POLD1—uterine cancer	1.73e-05	0.000428	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.69e-05	0.000418	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.69e-05	0.000418	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—CYP19A1—uterine cancer	1.68e-05	0.000414	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—STK11—uterine cancer	1.68e-05	0.000414	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NDUFB11—uterine cancer	1.65e-05	0.000408	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SRD5A2—uterine cancer	1.65e-05	0.000408	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.64e-05	0.000406	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKR1C1—uterine cancer	1.62e-05	0.000401	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.59e-05	0.000394	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—RRM2—uterine cancer	1.59e-05	0.000393	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.57e-05	0.000389	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.57e-05	0.000388	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.56e-05	0.000385	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.56e-05	0.000385	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.55e-05	0.000384	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.54e-05	0.000381	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.54e-05	0.000381	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—DCN—uterine cancer	1.54e-05	0.000381	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.5e-05	0.000371	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.5e-05	0.00037	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—STAR—uterine cancer	1.49e-05	0.00037	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKR1B1—uterine cancer	1.49e-05	0.00037	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	1.48e-05	0.000366	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.48e-05	0.000365	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP11A1—uterine cancer	1.45e-05	0.000359	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—STK11—uterine cancer	1.45e-05	0.000358	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—CYP19A1—uterine cancer	1.45e-05	0.000358	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—RRM2—uterine cancer	1.44e-05	0.000357	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.42e-05	0.00035	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—CYP19A1—uterine cancer	1.41e-05	0.000349	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—STK11—uterine cancer	1.41e-05	0.000349	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—DCN—uterine cancer	1.4e-05	0.000347	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.39e-05	0.000343	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKR1C3—uterine cancer	1.37e-05	0.000339	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—STAR—uterine cancer	1.37e-05	0.000339	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.37e-05	0.000339	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.35e-05	0.000335	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.32e-05	0.000327	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP11A1—uterine cancer	1.32e-05	0.000327	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.32e-05	0.000326	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.32e-05	0.000326	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.28e-05	0.000317	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.28e-05	0.000317	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.26e-05	0.000312	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—MTHFR—uterine cancer	1.26e-05	0.000311	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKR1C3—uterine cancer	1.25e-05	0.000308	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.22e-05	0.000302	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—STAR—uterine cancer	1.22e-05	0.000302	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.21e-05	0.0003	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.21e-05	0.000299	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.21e-05	0.000299	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKR1B1—uterine cancer	1.19e-05	0.000295	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—STAR—uterine cancer	1.19e-05	0.000295	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.18e-05	0.000292	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—POLD1—uterine cancer	1.17e-05	0.00029	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.13e-05	0.000279	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.13e-05	0.000278	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—STAR—uterine cancer	1.13e-05	0.000278	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—STAR—uterine cancer	1.12e-05	0.000276	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.12e-05	0.000276	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.11e-05	0.000274	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.1e-05	0.000273	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKR1C1—uterine cancer	1.1e-05	0.000271	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—MTHFR—uterine cancer	1.09e-05	0.000269	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—POLD1—uterine cancer	1.08e-05	0.000266	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—STK11—uterine cancer	1.07e-05	0.000264	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP19A1—uterine cancer	1.07e-05	0.000264	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.07e-05	0.000264	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—MTHFR—uterine cancer	1.06e-05	0.000262	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.02e-05	0.000252	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.02e-05	0.000252	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.01e-05	0.000249	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1e-05	0.000248	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—RRM2—uterine cancer	9.78e-06	0.000242	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—STK11—uterine cancer	9.72e-06	0.00024	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP19A1—uterine cancer	9.72e-06	0.00024	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—POLD1—uterine cancer	9.6e-06	0.000237	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.57e-06	0.000236	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKR1B1—uterine cancer	9.53e-06	0.000236	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—STAR—uterine cancer	9.53e-06	0.000236	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—DCN—uterine cancer	9.49e-06	0.000235	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.42e-06	0.000233	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—POLD1—uterine cancer	9.37e-06	0.000232	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.34e-06	0.000231	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.07e-06	0.000224	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKR1C1—uterine cancer	8.98e-06	0.000222	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—RRM2—uterine cancer	8.97e-06	0.000222	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP11A1—uterine cancer	8.94e-06	0.000221	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—POLD1—uterine cancer	8.83e-06	0.000218	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKR1C1—uterine cancer	8.76e-06	0.000217	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—POLD1—uterine cancer	8.75e-06	0.000216	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—DCN—uterine cancer	8.7e-06	0.000215	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKR1C3—uterine cancer	8.45e-06	0.000209	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.34e-06	0.000206	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKR1C1—uterine cancer	8.26e-06	0.000204	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP11A1—uterine cancer	8.2e-06	0.000203	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKR1C1—uterine cancer	8.19e-06	0.000202	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.06e-06	0.000199	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—MTHFR—uterine cancer	8.03e-06	0.000199	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—RRM2—uterine cancer	8e-06	0.000198	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—RRM2—uterine cancer	7.81e-06	0.000193	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—DCN—uterine cancer	7.77e-06	0.000192	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKR1C3—uterine cancer	7.74e-06	0.000191	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—DCN—uterine cancer	7.58e-06	0.000187	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—POLD1—uterine cancer	7.48e-06	0.000185	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—RRM2—uterine cancer	7.36e-06	0.000182	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—STAR—uterine cancer	7.36e-06	0.000182	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKR1B1—uterine cancer	7.36e-06	0.000182	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP11A1—uterine cancer	7.32e-06	0.000181	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—MTHFR—uterine cancer	7.31e-06	0.000181	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—RRM2—uterine cancer	7.3e-06	0.00018	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—DCN—uterine cancer	7.15e-06	0.000177	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP11A1—uterine cancer	7.14e-06	0.000177	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—DCN—uterine cancer	7.08e-06	0.000175	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.08e-06	0.000175	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTEN—uterine cancer	7e-06	0.000173	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKR1C1—uterine cancer	7e-06	0.000173	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKR1C3—uterine cancer	6.91e-06	0.000171	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	6.81e-06	0.000168	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKR1C3—uterine cancer	6.75e-06	0.000167	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP11A1—uterine cancer	6.73e-06	0.000166	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—EP300—uterine cancer	6.68e-06	0.000165	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP11A1—uterine cancer	6.67e-06	0.000165	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—STK11—uterine cancer	6.58e-06	0.000163	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CYP19A1—uterine cancer	6.58e-06	0.000163	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKR1C3—uterine cancer	6.36e-06	0.000157	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKR1C3—uterine cancer	6.3e-06	0.000156	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—RRM2—uterine cancer	6.24e-06	0.000154	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.18e-06	0.000153	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTEN—uterine cancer	6.06e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—DCN—uterine cancer	6.05e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—STK11—uterine cancer	6.03e-06	0.000149	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP19A1—uterine cancer	6.03e-06	0.000149	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTEN—uterine cancer	5.89e-06	0.000146	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.89e-06	0.000146	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—EP300—uterine cancer	5.78e-06	0.000143	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—POLD1—uterine cancer	5.77e-06	0.000143	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP11A1—uterine cancer	5.7e-06	0.000141	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.66e-06	0.00014	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—EP300—uterine cancer	5.62e-06	0.000139	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.4e-06	0.000134	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.4e-06	0.000133	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKR1C3—uterine cancer	5.39e-06	0.000133	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—STK11—uterine cancer	5.39e-06	0.000133	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP19A1—uterine cancer	5.39e-06	0.000133	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP19A1—uterine cancer	5.26e-06	0.00013	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—STK11—uterine cancer	5.26e-06	0.00013	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.06e-06	0.000125	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—STK11—uterine cancer	4.95e-06	0.000122	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP19A1—uterine cancer	4.95e-06	0.000122	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—MTHFR—uterine cancer	4.95e-06	0.000122	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—uterine cancer	4.94e-06	0.000122	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP19A1—uterine cancer	4.91e-06	0.000121	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—STK11—uterine cancer	4.91e-06	0.000121	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.82e-06	0.000119	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—RRM2—uterine cancer	4.81e-06	0.000119	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—DCN—uterine cancer	4.67e-06	0.000115	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.61e-06	0.000114	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—MTHFR—uterine cancer	4.53e-06	0.000112	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—uterine cancer	4.47e-06	0.00011	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.4e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.4e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.36e-06	0.000108	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—uterine cancer	4.27e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—EP300—uterine cancer	4.26e-06	0.000105	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—STK11—uterine cancer	4.2e-06	0.000104	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.2e-06	0.000104	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—uterine cancer	4.16e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.16e-06	0.000103	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—uterine cancer	4.06e-06	0.0001	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—MTHFR—uterine cancer	4.05e-06	0.0001	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—AKT1—uterine cancer	4.04e-06	9.98e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4e-06	9.88e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—MTHFR—uterine cancer	3.95e-06	9.76e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.94e-06	9.74e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—EP300—uterine cancer	3.88e-06	9.58e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.76e-06	9.29e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—MTHFR—uterine cancer	3.72e-06	9.2e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—MTHFR—uterine cancer	3.69e-06	9.12e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.57e-06	8.82e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—AKT1—uterine cancer	3.49e-06	8.63e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—AKT1—uterine cancer	3.4e-06	8.4e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.25e-06	8.04e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—STK11—uterine cancer	3.24e-06	8.01e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.24e-06	8.01e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—MTHFR—uterine cancer	3.15e-06	7.79e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—uterine cancer	3.15e-06	7.79e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—uterine cancer	2.87e-06	7.09e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.78e-06	6.87e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—uterine cancer	2.75e-06	6.8e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—EP300—uterine cancer	2.62e-06	6.49e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—AKT1—uterine cancer	2.57e-06	6.36e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—uterine cancer	2.52e-06	6.23e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—MTHFR—uterine cancer	2.43e-06	6.02e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—EP300—uterine cancer	2.41e-06	5.95e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—AKT1—uterine cancer	2.34e-06	5.79e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—uterine cancer	2.25e-06	5.57e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—uterine cancer	2.2e-06	5.43e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—EP300—uterine cancer	2.15e-06	5.31e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—EP300—uterine cancer	2.1e-06	5.18e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—uterine cancer	2.07e-06	5.12e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—uterine cancer	2.05e-06	5.07e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—EP300—uterine cancer	1.97e-06	4.88e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—EP300—uterine cancer	1.96e-06	4.84e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—uterine cancer	1.94e-06	4.8e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.78e-06	4.4e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—uterine cancer	1.75e-06	4.34e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—EP300—uterine cancer	1.67e-06	4.14e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.59e-06	3.93e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—AKT1—uterine cancer	1.59e-06	3.92e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—uterine cancer	1.55e-06	3.83e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.46e-06	3.61e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—AKT1—uterine cancer	1.45e-06	3.59e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.45e-06	3.58e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—uterine cancer	1.35e-06	3.35e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—AKT1—uterine cancer	1.3e-06	3.21e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—EP300—uterine cancer	1.29e-06	3.19e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—AKT1—uterine cancer	1.27e-06	3.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.24e-06	3.06e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—AKT1—uterine cancer	1.19e-06	2.95e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—AKT1—uterine cancer	1.18e-06	2.92e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—AKT1—uterine cancer	1.01e-06	2.5e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—uterine cancer	9.55e-07	2.36e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—AKT1—uterine cancer	7.8e-07	1.93e-05	CbGpPWpGaD
